Tyrosine kinase inhibitors are potent acute pulmonary vasodilators in rats (Q42105103)

16 October 2017

Tyrosine kinase inhibitors are potent acute pulmonary vasodilators in rats (English)

1 reference

16 October 2017

William T. Gerthoffer

8

1 reference

16 October 2017

Abdallah Alzoubi

3

0 references

author name string

Kohtaro Abe

1

1 reference

16 October 2017

Michie Toba

2

1 reference

16 October 2017

Karel Koubsky

4

1 reference

16 October 2017

Masako Ito

5

1 reference

16 October 2017

Hiroki Ota

6

1 reference

16 October 2017

Salina Gairhe

7

1 reference

16 October 2017

Karen A Fagan

9

1 reference

16 October 2017

Ivan F McMurtry

10

1 reference

16 October 2017

Masahiko Oka

11

1 reference

16 October 2017

4 March 2011

1 reference

American Journal of Respiratory Cell and Molecular Biology

16 October 2017

1 reference

16 October 2017

45

1 reference

16 October 2017

4

1 reference

16 October 2017

804-808

1 reference

Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy.

16 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5460892

Rho kinase-mediated vasoconstriction in pulmonary hypertension

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5460892

Regulation of smooth muscle contraction by small GTPases

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5460892

Nilotinib: a second-generation tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5460892

Thromboxane A2-induced bi-directional regulation of cerebral arterial tone

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5460892

Combined tyrosine and serine/threonine kinase inhibition by sorafenib prevents progression of experimental pulmonary hypertension and myocardial remodeling

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5460892

Therapeutic potential of RhoA/Rho kinase inhibitors in pulmonary hypertension

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5460892

Genomic assessment of a multikinase inhibitor, sorafenib, in a rodent model of pulmonary hypertension

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5460892

Physiologic properties and regulation of the actin cytoskeleton in vascular smooth muscle

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5460892

Interaction between src family kinases and rho-kinase in agonist-induced Ca2+-sensitization of rat pulmonary artery.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5460892

Therapeutic potential of the epidermal growth factor receptor transactivation in hypertension: a convergent signaling pathway of vascular tone, oxidative stress, and hypertrophic growth downstream of vasoactive G-protein-coupled receptors?

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5460892

Discovery and development of sorafenib: a multikinase inhibitor for treating cancer.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5460892

Cardiotoxicity of the cancer therapeutic agent imatinib mesylate.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5460892

Reversal of experimental pulmonary hypertension by PDGF inhibition

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5460892

Thromboxane A2-induced contraction of rat caudal arterial smooth muscle involves activation of Ca2+ entry and Ca2+ sensitization: Rho-associated kinase-mediated phosphorylation of MYPT1 at Thr-855, but not Thr-697

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5460892

The development of imatinib as a therapeutic agent for chronic myeloid leukemia

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5460892

Treatment of pulmonary arterial hypertension

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5460892

Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5460892

Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5460892

Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5460892

Increase in tone and intracellular Ca2+ in rabbit isolated ear artery by platelet-derived growth factor

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5460892

Role of protein kinase C-mediated pathway in the pathogenesis of coronary artery spasm in a swine model

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5460892

Vasoactive effects of growth factors

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5460892

Rho-kinase-mediated regulation of receptor-agonist-stimulated smooth muscle contraction.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5460892

Imatinib for the treatment of pulmonary arterial hypertension

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5460892

Imatinib Mesylate in the Treatment of Refractory Idiopathic Pulmonary Arterial Hypertension

17 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1165%2FRCMB.2010-0371OC

Tyrphostin attenuates platelet-derived growth factor-induced contraction in aortic smooth muscle through inhibition of protein tyrosine kinase(s)

21 January 2018

1 reference

12 December 2020

Epidermal growth factor: a potent vasoconstrictor in experimental hypertension

1 reference

12 December 2020

Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats

1 reference

12 December 2020

EDRF suppresses an unidentified vasoconstrictor mechanism in hypertensive rat lungs

1 reference

12 December 2020

Identifiers

DOI

10.1165/RCMB.2010-0371OC

1 reference

16 October 2017

1 reference

16 October 2017

1 reference